Despite a 25% drop in earnings per share, Coronation Fund Managers (JSE:CML) delivered a robust 57% total shareholder return over the past year, driven by revenue growth and strong market sentiment, outperforming the broader South African market.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
French IT giant Capgemini moves to sell its U.S. government solutions subsidiary following political and internal pressure over its contract with Immigration and Customs Enforcement (ICE), as public debate intensifies around tech's role in immigration enforcement.
As diplomatic efforts to secure a ceasefire in Gaza show fragile progress, Israeli airstrikes have resulted in the deaths of at least 30 Palestinians overnight, with multiple children among the casualties, according to local health authorities.
Backed by a major U.S. government loan and a surge in private equity, USA Rare Earth is accelerating its domestic mining and manufacturing projects, positioning itself at the forefront of a critical national strategy.
Backed by regional sovereign wealth giants, Ruya Partners is launching a $400 million fund to address middle-market lending gaps in Saudi Arabia and the UAE, positioning itself as a key player in the Gulf's burgeoning private credit landscape.
Facing rising US tariffs and global supply chain pressures, India's latest budget prioritizes strategic sectors and export support while maintaining fiscal discipline, signaling a cautious pivot toward economic resilience.
Chinese authorities have executed four individuals convicted of leading a massive online fraud and gambling ring based in Myanmar, linked to over $4 billion in illicit proceeds and the deaths of six Chinese nationals. The move is part of a widening crackdown on cross-border criminal networks targeting Chinese citizens.
Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.
Aalberts N.V. (AMS:AALB), a mid-cap specialist in industrial technology, has seen a significant price surge on the ENXTAM, prompting analysts to revisit its valuation and growth trajectory amidst market volatility.
Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.
The London-listed gold miner AltynGold is turning heads with a remarkable 43% return on capital employed, significantly outpacing industry averages and fueling investor optimism about its expansion potential.
A fabricated email alleging Jeffrey Epstein discussed Bitcoin's launch with Ghislaine Maxwell has spread online. While the viral message is false, newly released court documents contain genuine references to the cryptocurrency's pseudonymous founder.
While investors chase pure-play AI stocks, cybersecurity leader CrowdStrike demonstrates how leveraging AI defensively within a robust platform model can drive sustained, profitable growth amid escalating digital threats.
A surge of competitively priced Chinese electric vehicles and consumer goods is rapidly transforming Latin American markets, forcing governments from Mexico to Brazil to enact new tariffs and trade defenses to shield domestic industries from the influx.
In a tense Sunday interview, ABC's George Stephanopoulos confronted Deputy Attorney General Todd Blanche about a Wall Street Journal investigation revealing a major investment by a UAE security official into a cryptocurrency company founded by Donald Trump.
Shares of security products giant Allegion have gained significant momentum, delivering a 26% total return over the past year. With the stock now trading near $165, we examine whether its current valuation still offers an attractive entry point or if future growth is already priced in.
Shares of Tyson Foods (TSN) have climbed over 12% in the past month, reigniting discussions on Wall Street about the meatpacking giant's valuation. While some analysts see room for further growth, others caution that recent gains may have outpaced fundamentals.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
As Virgin Galactic's stock hovers near historic lows, the market is grappling with a critical question: Is the pioneering space tourism company a deeply undervalued opportunity, or a speculative bet burdened by persistent losses and ambitious, yet unproven, timelines?
